Sex drives dimorphic immune responses to viral infections

Journal of Immunology

Volumn 198, Issue 5, 2017, Pages 1782-1790

  Ghosh, Soumitra ^a   Klein, Robyn S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CYCLIC AMP; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE; PROTEIN KINASE C; SOMATOMEDIN C; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TESTOSTERONE; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR; SEX HORMONE;

ADAPTIVE IMMUNITY; AVIAN INFLUENZA (H5N1); B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COXSACKIE VIRUS INFECTION; COXSACKIEVIRUS B3; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; DISEASE COURSE; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; ENZYME ACTIVATION; HANTAVIRUS INFECTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMORAL IMMUNITY; INFLUENZA A (H1N1); INFLUENZA A (H2N2); INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H2N2); INFLUENZA A VIRUS (H5N1); INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN LOCALIZATION; PUUMALA VIRUS; PUUMALA VIRUS INFECTION; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; ANIMAL; AUTOIMMUNITY; FEMALE; IMMUNOLOGY; MALE; PHYSIOLOGY; SEX CHROMOSOME; SEXUAL DEVELOPMENT; VIROLOGY; VIRUS DISEASES;

ANIMALS; AUTOIMMUNITY; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; SEX CHARACTERISTICS; SEX CHROMOSOMES; VIRUS DISEASES;

EID: 85014882617     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601166     Document Type: Review

References (158)

1. Marriott, I., and Y. M. Huet-Hudson. 2006. Sexual dimorphism in innate immune responses to infectious organisms. Immunol. Res. 34: 177-192.
2. Butterworth, M., B. McClellan, and M. Allansmith. 1967. Influence of sex in immunoglobulin levels. Nature 214: 1224-1225.
3. Klein, S. L., and K. L. Flanagan. 2016. Sex differences in immune responses. Nat. Rev. Immunol. 16: 626-638.
4. Klein, S. L. 2012. Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases. BioEssays 34: 1050-1059.
5. Larcombe, A. N., R. E. Foong, E. M. Bozanich, L. J. Berry, L. W. Garratt, R. C. Gualano, J. E. Jones, L. F. Dousha, G. R. Zosky, and P. D. Sly. 2011. Sexual dimorphism in lung function responses to acute influenza A infection. Influenza Other Respi. Viruses 5: 334-342.
6. Molina, V., and Y. Shoenfeld. 2005. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 38: 235-245.
7. Lamason, R., P. Zhao, R. Rawat, A. Davis, J. C. Hall, J. J. Chae, R. Agarwal, P. Cohen, A. Rosen, E. P. Hoffman, and K. Nagaraju. 2006. Sexual dimorphism in immune response genes as a function of puberty. BMC Immunol. 7: 2.
8. Luppi, P., C. Haluszczak, D. Betters, C. A. Richard, M. Trucco, and J. A. DeLoia. 2002. Monocytes are progressively activated in the circulation of pregnant women. J. Leukoc. Biol. 72: 874-884.
9. Kaushic, C., K. L. Roth, V. Anipindi, and F. Xiu. 2011. Increased prevalence of sexually transmitted viral infections in women: the role of female sex hormones in regulating susceptibility and immune responses. J. Reprod. Immunol. 88: 204-209.
10. Oertelt-Prigione, S. 2012. The influence of sex and gender on the immune response. Autoimmun. Rev. 11: A479-A485.
11. Klein, S. L., I. Marriott, and E. N. Fish. 2015. Sex-based differences in immune function and responses to vaccination. Trans. R. Soc. Trop. Med. Hyg. 109: 9-15.
12. Fischer, J., N. Jung, N. Robinson, and C. Lehmann. 2015. Sex differences in immune responses to infectious diseases. Infection 43: 399-403.
13. Wang, J., C. M. Syrett, M. C. Kramer, A. Basu, M. L. Atchison, and M. C. Anguera. 2016. Unusual maintenance of X chromosome inactivation predisposes female lymphocytes for increased expression from the inactive X. Proc. Natl. Acad. Sci. USA 113: E2029-E2038.
14. Dixon-McDougall, T., and C. Brown. 2016. The making of a Barr body: the mosaic of factors that eXIST on the mammalian inactive X chromosome. Biochem. Cell Biol. 94: 56-70.
15. Barrionuevo, F., S. Bagheri-Fam, J. Klattig, R. Kist, M. M. Taketo, C. Englert, and G. Scherer. 2006. Homozygous inactivation of Sox9 causes complete XY sex reversal in mice. Biol. Reprod. 74: 195-201.
16. Hannah, M. F., V. B. Bajic, and S. L. Klein. 2008. Sex differences in the recognition of and innate antiviral responses to Seoul virus in Norway rats. Brain Behav. Immun. 22: 503-516.
17. Geurs, T. L., E. B. Hill, D. M. Lippold, and A. R. French. 2012. Sex differences in murine susceptibility to systemic viral infections. J. Autoimmun. 38: J245-J253.
18. Hagen, S., and M. Altfeld. 2016. The X awakens: multifactorial ramifications of sex-specific differences in HIV-1 infection. J Virus Erad 2: 78-81.
19. Fish, E. N. 2008. The X-files in immunity: sex-based differences predispose immune responses. Nat. Rev. Immunol. 8: 737-744.
20. Peretz, J., A. Pekosz, A. P. Lane, and S. L. Klein. 2016. Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors. Am. J. Physiol. Lung Cell. Mol. Physiol. 310: L415-L425.
21. Bermejo-Alvarez, P., D. Rizos, P. Lonergan, and A. Gutierrez-Adan. 2011. Transcriptional sexual dimorphism during preimplantation embryo development and its consequences for developmental competence and adult health and disease. Reproduction 141: 563-570.
22. Lowe, R., C. Gemma, V. K. Rakyan, and M. L. Holland. 2015. Sexually dimorphic gene expression emerges with embryonic genome activation and is dynamic throughout development. BMC Genomics 16: 295.
23. Sekido, R., and R. Lovell-Badge. 2008. Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 453: 930-934.
24. Case, L. K., L. Toussaint, M. Moussawi, B. Roberts, N. Saligrama, L. Brossay, S. A. Huber, and C. Teuscher. 2012. Chromosome y regulates survival following murine coxsackievirus b3 infection. G3 2: 115-121.
25. Makiyan, Z. 2016. Studies of gonadal sex differentiation. Organogenesis 12: 42-51.
26. Durando, M., L. Cocito, H. A. Rodŕguez, J. Varayoud, J. G. Ramos, E. H. Luque, and M. Munõz-de-Toro. 2013. Neonatal expression of amh, sox9 and sf-1 mRNA in Caiman latirostris and effects of in ovo exposure to endocrine disrupting chemicals. Gen. Comp. Endocrinol. 191: 31-38.
27. Lavery, R., A. A. Chassot, E. Pauper, E. P. Gregoire, M. Klopfenstein,D. G. de Rooij, M. Mark, A. Schedl, N. B. Ghyselinck, and M. C. Chaboissier. 2012. Testicular differentiation occurs in absence of R-spondin1 and Sox9 in mouse sex reversals. PLoS Genet. 8: e1003170.
28. Tomizuka, K., K. Horikoshi, R. Kitada, Y. Sugawara, Y. Iba, A. Kojima, A. Yoshitome, K. Yamawaki, M. Amagai, A. Inoue, et al. 2008. R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signaling. Hum. Mol. Genet. 17: 1278-1291.
29. Chassot, A. A., F. Ranc, E. P. Gregoire, H. L. Roepers-Gajadien, M. M. Taketo, G. Camerino, D. G. de Rooij, A. Schedl, and M. C. Chaboissier. 2008. Activation of beta-catenin signaling by Rspo1 controls differentiation of the mammalian ovary. Hum. Mol. Genet. 17: 1264-1277.
30. Smith, C. A., C. M. Shoemaker, K. N. Roeszler, J. Queen, D. Crews, and A. H. Sinclair. 2008. Cloning and expression of R-Spondin1 in different vertebrates suggests a conserved role in ovarian development. BMC Dev. Biol. 8: 72.
31. Kim, Y., A. Kobayashi, R. Sekido, L. DiNapoli, J. Brennan, M. C. Chaboissier, F. Poulat, R. R. Behringer, R. Lovell-Badge, and B. Capel. 2006. Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biol. 4: e187.
32. Schmidt, D., C. E. Ovitt, K. Anlag, S. Fehsenfeld, L. Gredsted, A. C. Treier, and M. Treier. 2004. The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131: 933-942.
33. Ottolenghi, C., S. Omari, J. E. Garcia-Ortiz, M. Uda, L. Crisponi, A. Forabosco, G. Pilia, and D. Schlessinger. 2005. Foxl2 is required for commitment to ovary differentiation. Hum. Mol. Genet. 14: 2053-2062.
34. Uhlenhaut, N. H., S. Jakob, K. Anlag, T. Eisenberger, R. Sekido, J. Kress, A. C. Treier, C. Klugmann, C. Klasen, N. I. Holter, et al. 2009. Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell 139: 1130-1142.
35. Kashimada, K., T. Svingen, C. W. Feng, E. Pelosi, S. Bagheri-Fam, V. R. Harley, D. Schlessinger, J. Bowles, and P. Koopman. 2011. Antagonistic regulation of Cyp26b1 by transcription factors SOX9/SF1 and FOXL2 during gonadal development in mice. FASEB J. 25: 3561-3569.
36. Matson, C. K., M. W. Murphy, A. L. Sarver, M. D. Griswold, V. J. Bardwell, and D. Zarkower. 2011. DMRT1 prevents female reprogramming in the postnatal mammalian testis. Nature 476: 101-104.
37. Kovats, S. 2015. Estrogen receptors regulate innate immune cells and signaling pathways. Cell. Immunol. 294: 63-69.
38. Tejera-Alhambra, M., B. Alonso, R. Teijeiro, R. Ramos-Medina, C. Aristimunõ, L. Valor, C. de Andrés, and S. Sánchez-Ramón. 2012. Perforin expression by CD4+ regulatory T cells increases at multiple sclerosis relapse: sex differences. Int. J. Mol. Sci. 13: 6698-6710.
39. McCarthy, M. M., and A. P. Arnold. 2011. Reframing sexual differentiation of the brain. Nat. Neurosci. 14: 677-683.
40. Azad, N., N. LaPaglia, L. Agrawal, J. Steiner, S. Uddin, D. W. Williams, A. M. Lawrence, and N. V. Emanuele. 1998. The role of gonadectomy and testosterone replacement on thymic luteinizing hormone-releasing hormone production. J. Endocrinol. 158: 229-235.
41. Hines, M., V. Pasterski, D. Spencer, S. Neufeld, P. Patalay, P. C. Hindmarsh, I. A. Hughes, and C. L. Acerini. 2016. Prenatal androgen exposure alters girls' responses to information indicating gender-appropriate behaviour. Philos. Trans. R. Soc. Lond. B Biol. Sci. 371: 20150125.
42. Konstadoulakis, M. M., K. N. Syrigos, C. N. Baxevanis, E. I. Syrigou, M. Papamichail, P. Peveretos, M. Anapliotou, and B. C. Golematis. 1995. Effect of testosterone administration, pre-and postnatally, on the immune system of rats. Horm. Metab. Res. 27: 275-278.
43. Weinstein, Y., S. Ran, and S. Segal. 1984. Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse. J. Immunol. 132: 656-661.
44. Amadori, A., R. Zamarchi, G. De Silvestro, G. Forza, G. Cavatton, G. A. Danieli, M. Clementi, and L. Chieco-Bianchi. 1995. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat. Med. 1: 1279-1283.
45. Gould, K. G., M. A. Akinbami, and D. R. Mann. 1998. Effect of neonatal treatment with a gonadotropin releasing hormone antagonist on developmental changes in circulating lymphocyte subsets: a longitudinal study in male rhesus monkeys. Dev. Comp. Immunol. 22: 457-467.
46. Mann, D. R., and H. M. Fraser. 1996. The neonatal period: a critical interval in male primate development. J. Endocrinol. 149: 191-197.
47. Page, S. T., S. R. Plymate, W. J. Bremner, A. M. Matsumoto, D. L. Hess, D. W. Lin, J. K. Amory, P. S. Nelson, and J. D. Wu. 2006. Effect of medical castration on CD4+ CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: a physiological role for testosterone and/or its metabolites. Am. J. Physiol. Endocrinol. Metab. 290: E856-E863.
48. Paavonen, T., L. C. Andersson, and H. Adlercreutz. 1981. Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J. Exp. Med. 154: 1935-1945.
49. Sthoeger, Z. M., N. Chiorazzi, and R. G. Lahita. 1988. Regulation of the immune response by sex hormones. I. In vitro effects of estradiol and testosterone on pokeweed mitogen-induced human B cell differentiation. J. Immunol. 141: 91-98.
50. Ainbender, E., R. B. Weisinger, M. Hevizy, and H. L. Hodes. 1968. Difference in the immunoglobulin class of polioantibody in the serum of men and women. J. Immunol. 101: 92-98.
51. Muller, W., T. G. Groothuis, A. Kasprzik, C. Dijkstra, R. V. Alatalo, and H. Siitari. 2005. Prenatal androgen exposure modulates cellular and humoral immune function of black-headed gull chicks. Proc. Biol. Sci. 272: 1971-1977.
52. Arnold, A. P. 2009. The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues. Horm. Behav. 55: 570-578.
53. Gaumond, I., P. Arsenault, and S. Marchand. 2002. The role of sex hormones on formalin-induced nociceptive responses. Brain Res. 958: 139-145.
54. Lai, J. J., K. P. Lai, W. Zeng, K. H. Chuang, S. Altuwaijri, and C. Chang. 2012. Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: lessons from conditional AR knockout mice. Am. J. Pathol. 181: 1504-1512.
55. Nilsson, S., S. Mäkelä, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J. A. Gustafsson. 2001. Mechanisms of estrogen action. Physiol. Rev. 81: 1535-1565.
56. Phiel, K. L., R. A. Henderson, S. J. Adelman, and M. M. Elloso. 2005. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol. Lett. 97: 107-113.
57. Nakada, D., H. Oguro, B. P. Levi, N. Ryan, A. Kitano, Y. Saitoh, M. Takeichi, G. R. Wendt, and S. J. Morrison. 2014. Oestrogen increases haematopoietic stemcell self-renewal in females and during pregnancy. Nature 505: 555-558.
58. Bird, M. D., J. Karavitis, and E. J. Kovacs. 2008. Sex differences and estrogen modulation of the cellular immune response after injury. Cell. Immunol. 252: 57-67.
59. Zhou, T., Z. Yang, Y. Chen, Y. Chen, Z. Huang, B. You, Y. Peng, and J. Chen. 2016. Estrogen accelerates cutaneous wound healing by promoting proliferation of epidermal keratinocytes via Erk/Akt signaling pathway. Cell. Physiol. Biochem. 38: 959-968.
60. Xie, H., C. Hua, L. Sun, X. Zhao, H. Fan, H. Dou, L. Sun, and Y. Hou. 2011. 17b-estradiol induces CD40 expression in dendritic cells via MAPK signaling pathways in a minichromosome maintenance protein 6-dependent manner. Arthritis Rheum. 63: 2425-2435.
61. Douin-Echinard, V., S. Laffont, C. Seillet, L. Delpy, A. Krust, P. Chambon, P. Gourdy, J. F. Arnal, and J. C. Guéry. 2008. Estrogen receptor alpha, but not beta, is required for optimal dendritic cell differentiation and [corrected] CD40-induced cytokine production. [Published erratum appears in 2008 J. Immunol. 180: 7047.] J. Immunol. 180: 3661-3669.
62. Carascossa, S., P. Dudek, B. Cenni, P. A. Briand, and D. Picard. 2010. CARM1 mediates the ligand-independent and tamoxifen-resistant activation of the estrogen receptor alpha by cAMP. Genes Dev. 24: 708-719.
63. Murphy, A. J., P. M. Guyre, C. R. Wira, and P. A. Pioli. 2009. Estradiol regulates expression of estrogen receptor ERalpha46 in human macrophages. PLoS One 4: e5539.
64. Lasarte, S., D. Elsner, T. Sanchez-Elsner, A. Fernandez-Pineda, L. A. López-Fernández, A. L. Corb, M. A. Munõz-Fernandez, and M. Relloso. 2013. Estradiol downregulates NF-kb translocation by Ikbkg transcriptional repression in dendritic cells. Genes Immun. 14: 462-469.
65. Ho, H. H., and L. B. Ivashkiv. 2006. Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation. J. Biol. Chem. 281: 14111-14118.
66. Kuchipudi, S. V. 2015. The complex role of STAT3 in viral infections. J. Immunol. Res. 2015: 272359. Available at: http://dx.doi.org/10.1155/2015/ 272359.
67. Alexander, W. S., R. Starr, J. E. Fenner, C. L. Scott, E. Handman, N. S. Sprigg, J. E. Corbin, A. L. Cornish, R. Darwiche, C. M. Owczarek, et al. 1999. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98: 597-608.
68. Kinjyo, I., T. Hanada, K. Inagaki-Ohara, H. Mori, D. Aki, M. Ohishi, H. Yoshida, M. Kubo, and A. Yoshimura. 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17: 583-591.
69. Cornish, A. L., G. M. Davey, D. Metcalf, J. F. Purton, J. E. Corbin, C. J. Greenhalgh, R. Darwiche, L. Wu, N. A. Nicola, D. I. Godfrey, et al. 2003. Suppressor of cytokine signaling-1 has IFN-gamma-independent actions in T cell homeostasis. J. Immunol. 170: 878-886.
70. Brender, C., R. Columbus, D. Metcalf, E. Handman, R. Starr, N. Huntington, D. Tarlinton, N. Ødum, S. E. Nicholson, N. A. Nicola, et al. 2004. SOCS5 is expressed in primary B and T lymphoid cells but is dispensable for lymphocyte production and function. Mol. Cell. Biol. 24: 6094-6103.
71. Pan, T., L. Zhong, S. Wu, Y. Cao, Q. Yang, Z. Cai, X. Cai, W. Zhao, N. Ma, W. Zhang, et al. 2016. 17b-Oestradiol enhances the expansion and activation of myeloid-derived suppressor cells via signal transducer and activator of transcription (STAT)-3 signaling in human pregnancy. Clin. Exp. Immunol. 185: 86-97.
72. Kawana, K., Y. Kawana, and D. J. Schust. 2005. Female steroid hormones use signal transducers and activators of transcription protein-mediated pathways to modulate the expression of T-bet in epithelial cells: a mechanism for local immune regulation in the human reproductive tract. Mol. Endocrinol. 19: 2047-2059.
73. Schwarz, J. M., B. M. Nugent, and M. M. McCarthy. 2010. Developmental and hormone-induced epigenetic changes to estrogen and progesterone receptor genes in brain are dynamic across the life span. Endocrinology 151: 4871-4881.
74. Pedram, A., M. Razandi, M. Lewis, S. Hammes, and E. R. Levin. 2014. Membrane-localized estrogen receptor a is required for normal organ development and function. Dev. Cell 29: 482-490.
75. Zhang, X., K. Tanaka, J. Yan, J. Li, D. Peng, Y. Jiang, Z. Yang, M. C. Barton, H. Wen, and X. Shi. 2013. Regulation of estrogen receptor a by histone methyltransferase SMYD2-mediated protein methylation. Proc. Natl. Acad. Sci. USA 110: 17284-17289.
76. Edelmann, M. N., and A. P. Auger. 2011. Epigenetic impact of simulated maternal grooming on estrogen receptor alpha within the developing amygdala. Brain Behav. Immun. 25: 1299-1304.
77. Banchs, H. L., V. González, I. González Cancel, C. Quintana, R. Calderón, and P. I. Altieri. 2005. Heart transplantation in females: the experience in Puerto Rico. Bol. Asoc. Med. P. R. 97: 248-256.
78. Nalbandian, G., V. Paharkova-Vatchkova, A. Mao, S. Nale, and S. Kovats. 2005. The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation. J. Immunol. 175: 2666-2675.
79. Marino, M., P. Galluzzo, and P. Ascenzi. 2006. Estrogen signaling multiple pathways to impact gene transcription. Curr. Genomics 7: 497-508.
80. Johansen, L. M., J. M. Brannan, S. E. Delos, C. J. Shoemaker, A. Stossel, C. Lear, B. G. Hoffstrom, L. E. Dewald, K. L. Schornberg, C. Scully, et al. 2013. FDAapproved selective estrogen receptor modulators inhibit Ebola virus infection. Sci. Transl. Med. 5: 190ra79.
81. Wisdom, A. J., Y. Cao, N. Itoh, R. D. Spence, and R. R. Voskuhl. 2013. Estrogen receptor-b ligand treatment after disease onset is neuroprotective in the multiple sclerosis model. J. Neurosci. Res. 91: 901-908.
82. Butts, C. L., S. A. Shukair, K. M. Duncan, E. Bowers, C. Horn, E. Belyavskaya, L. Tonelli, and E. M. Sternberg. 2007. Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion. Int. Immunol. 19: 287-296.
83. Zhao, X., L. Liu, D. Liu, H. Fan, Y. Wang, Y. Hu, and Y. Hou. 2012. Progesterone enhances immunoregulatory activity of human mesenchymal stem cells via PGE2 and IL-6. Am. J. Reprod. Immunol. 68: 290-300.
84. Enninga, E. A., S. G. Holtan, D. J. Creedon, R. S. Dronca, W. K. Nevala, S. Ognjanovic, and S. N. Markovic. 2014. Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma. Mayo Clin. Proc. 89: 520-535.
85. Arruvito, L., S. Giulianelli, A. C. Flores, N. Paladino, M. Barboza, C. Lanari, and L. Fainboim. 2008. NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis. J. Immunol. 180: 5746-5753.
86. Llewelyn, D. E., G. F. Read, and S. G. Hillier. 1975. Proceedings: novel procedure for the simultaneous determination of testosterone and 5alpha-dihydrotestosterone concentrations in unpurified plasma extracts by radioimmunoassay. J. Endocrinol. 67: 7P-8P.
87. Penning, T. M., D. R. Bauman, Y. Jin, and T. L. Rizner. 2007. Identification of the molecular switch that regulates access of 5alpha-DHT to the androgen receptor. Mol. Cell. Endocrinol. 265-266: 77-82.
88. Chuang, K. H., S. Altuwaijri, G. Li, J. J. Lai, C. Y. Chu, K. P. Lai, H. Y. Lin, J. W. Hsu, P. Keng, M. C. Wu, and C. Chang. 2009. Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor. J. Exp. Med. 206: 1181-1199.
89. Lai, J. J., K. P. Lai, K. H. Chuang, P. Chang, I. C. Yu, W. J. Lin, and C. Chang. 2009. Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression. J. Clin. Invest. 119: 3739-3751.
90. Olsen, N. J., and W. J. Kovacs. 2001. Effects of androgens on T and B lymphocyte development. Immunol. Res. 23: 281-288.
91. Kissick, H. T., M. G. Sanda, L. K. Dunn, K. L. Pellegrini, S. T. On, J. K. Noel, and M. S. Arredouani. 2014. Androgens alter T-cell immunity by inhibiting Thelper 1 differentiation. Proc. Natl. Acad. Sci. USA 111: 9887-9892.
92. Benten, W. P., A. Becker, H. P. Schmitt-Wrede, and F. Wunderlich. 2002. Developmental regulation of intracellular and surface androgen receptors in T cells. Steroids 67: 925-931.
93. Lanini, S., A. Nanni Costa, P. A. Grossi, F. Procaccio, A. Ricci, M. R. Capobianchi, N. A. Terrault, and G. Ippolito. 2016. Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis. Liver Int. 36: 410-417.
94. Bao, M., Y. Yang, H. S. Jun, and J. W. Yoon. 2002. Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 168: 5369-5375.
95. Bebo, B. F., Jr., J. C. Schuster, A. A. Vandenbark, and H. Offner. 1999. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J. Immunol. 162: 35-40.
96. Arnold, A. P., X. Chen, and Y. Itoh. 2012. What a difference an X or Y makes: sex chromosomes, gene dose, and epigenetics in sexual differentiation. Handb. Exp. Pharmacol. 214: 67-88.
97. Ercan, S. 2015. Mechanisms of x chromosome dosage compensation. J Genomics 3: 1-19.
98. Simon, M. D., S. F. Pinter, R. Fang, K. Sarma, M. Rutenberg-Schoenberg, S. K. Bowman, B. A. Kesner, V. K. Maier, R. E. Kingston, and J. T. Lee. 2013. High-resolution Xist binding maps reveal two-step spreading during Xchromosome inactivation. Nature 504: 465-469.
99. Prokop, J. W., F. J. Rauscher III, H. Peng, Y. Liu, F. C. Araujo, I. Watanabe, F. M. Reis, and A. Milsted. 2014. MAS promoter regulation: a role for Sry and tyrosine nitration of the KRAB domain of ZNF274 as a feedback mechanism. Clin. Sci. 126: 727-738.
100. Oh, H. J., Y. Li, and Y. F. Lau. 2005. Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein. Biol. Reprod. 72: 407-415.
101. Tsai, H. W., P. A. Grant, and E. F. Rissman. 2009. Sex differences in histone modifications in the neonatal mouse brain. Epigenetics 4: 47-53.
102. Matsuda, K. I., H. Mori, B. M. Nugent, D. W. Pfaff, M. M. McCarthy, and M. Kawata. 2011. Histone deacetylation during brain development is essential for permanent masculinization of sexual behavior. Endocrinology 152: 2760-2767.
103. Wainwright, E. N., J. S. Jorgensen, Y. Kim, V. Truong, S. Bagheri-Fam, T. Davidson, T. Svingen, S. L. Fernandez-Valverde, K. S. McClelland, R. J. Taft, et al. 2013. SOX9 regulates microRNA miR-202-5p/3p expression during mouse testis differentiation. Biol. Reprod. 89: 34.
104. Wei, J., F. Wang, L. Y. Kong, S. Xu, T. Doucette, S. D. Ferguson, Y. Yang, K. McEnery, K. Jethwa, O. Gjyshi, et al. 2013. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res. 73: 3913-3926.
105. Jiang, S., C. Li, G. McRae, E. Lykken, J. Sevilla, S. Q. Liu, Y. Wan, and Q. J. Li. 2014. MeCP2 reinforces STAT3 signaling and the generation of effector CD4+ T cells by promoting miR-124-mediated suppression of SOCS5. Sci. Signal. 7: ra25.
106. Ponomarev, E. D., T. Veremeyko, N. Barteneva, A. M. Krichevsky, and H. L. Weiner. 2011. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-a-PU.1 pathway. Nat. Med. 17: 64-70.
107. Dillon, S. P., B. T. Kurien, S. Li, G. R. Bruner, K. M. Kaufman, J. B. Harley, P. M. Gaffney, D. J. Wallace, M. H. Weisman, and R. H. Scofield. 2012. Sex chromosome aneuploidies among men with systemic lupus erythematosus. J. Autoimmun. 38: J129-J134.
108. Smith-Bouvier, D. L., A. A. Divekar, M. Sasidhar, S. Du, S. K. Tiwari-Woodruff, J. K. King, A. P. Arnold, R. R. Singh, and R. R. Voskuhl. 2008. A role for sex chromosome complement in the female bias in autoimmune disease. J. Exp. Med. 205: 1099-1108.
109. Itoh, Y., R. Mackie, K. Kampf, S. Domadia, J. D. Brown, R. O'Neill, and A. P. Arnold. 2015. Four core genotypes mouse model: localization of the Sry transgene and bioassay for testicular hormone levels. BMC Res. Notes 8: 69.
110. Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.
111. Kanneganti, T. D., M. Lamkanfi, and G. Núnẽz. 2007. Intracellular NOD-like receptors in host defense and disease. Immunity 27: 549-559.
112. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
113. Cao, X. 2016. Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nat. Rev. Immunol. 16: 35-50.
114. Robinson, D. P., M. E. Lorenzo, W. Jian, and S. L. Klein. 2011. Elevated 17bestradiol protects females from influenza A virus pathogenesis by suppressing inflammatory responses. PLoS Pathog. 7: e1002149.
115. Meier, A., J. J. Chang, E. S. Chan, R. B. Pollard, H. K. Sidhu, S. Kulkarni, T. F. Wen, R. J. Lindsay, L. Orellana, D. Mildvan, et al. 2009. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat. Med. 15: 955-959.
116. Scotland, R. S., M. J. Stables, S. Madalli, P. Watson, and D. W. Gilroy. 2011. Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice. Blood 118: 5918-5927.
117. vom Steeg, L. G., and S. L. Klein. 2016. SeXX matters in infectious disease pathogenesis. PLoS Pathog. 12: e1005374.
118. Wikby, A., I. A. Månsson, B. Johansson, J. Strindhall, and S. E. Nilsson. 2008. The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age. Biogerontology 9: 299-308.
119. Kollias, C. M., R. B. Huneke, B. Wigdahl, and S. R. Jennings. 2015. Animal models of herpes simplex virus immunity and pathogenesis. J. Neurovirol. 21: 8-23.
120. Yirrell, D. L., W. A. Blyth, and T. J. Hill. 1987. The influence of androgens on paralysis in mice following intravenous inoculation of herpes simplex virus. J. Gen. Virol. 68: 2461-2464.
121. MacDonald, E. M., A. Savoy, A. Gillgrass, S. Fernandez, M. Smieja, K. L. Rosenthal, A. A. Ashkar, and C. Kaushic. 2007. Susceptibility of human female primary genital epithelial cells to herpes simplex virus, type-2 and the effect of TLR3 ligand and sex hormones on infection. Biol. Reprod. 77: 1049-1059.
122. Han, X., P. Lundberg, B. Tanamachi, H. Openshaw, J. Longmate, and E. Cantin. 2001. Gender influences herpes simplex virus type 1 infection in normal and gamma interferon-mutant mice. J. Virol. 75: 3048-3052.
123. Mueller, S. N., and L. K. Mackay. 2016. Tissue-resident memory T cells: local specialists in immune defence. Nat. Rev. Immunol. 16: 79-89.
124. van Lint, A., M. Ayers, A. G. Brooks, R. M. Coles, W. R. Heath, and F. R. Carbone. 2004. Herpes simplex virus-specific CD8+ T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation. J. Immunol. 172: 392-397.
125. Gillgrass, A. E., S. A. Fernandez, K. L. Rosenthal, and C. Kaushic. 2005. Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation. J. Virol. 79: 3107-3116.
126. Ragupathy, V., W. Xue, J. Tan, K. Devadas, Y. Gao, and I. Hewlett. 2016. Progesterone augments cell susceptibility to HIV-1 and HIV-1/HSV-2 co-infections. J. Mol. Endocrinol. 57: 185-199.
127. Vanćková, Z., and P. Dvorák. 2001. Cytomegalovirus infection in immunocompetent and immunocompromised individuals-a review. Curr. Drug Targets Immune Endocr. Metabol. Disord. 1: 179-187.
128. Chang, W. L., P. A. Barry, R. Szubin, D. Wang, and N. Baumgarth. 2009. Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology 390: 330-337.
129. Delale, T., A. Paquin, C. Asselin-Paturel, M. Dalod, G. Brizard, E. E. Bates, P. Kastner, S. Chan, S. Akira, A. Vicari, et al. 2005. MyD88-dependent and-independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo. J. Immunol. 175: 6723-6732.
130. Traub, S., O. Demaria, L. Chasson, F. Serra, B. Desnues, and L. Alexopoulou. 2012. Sex bias in susceptibility to MCMV infection: implication of TLR9. PLoS One 7: e45171.
131. Lester, S. N., and K. Li. 2014. Toll-like receptors in antiviral innate immunity. J. Mol. Biol. 426: 1246-1264.
132. Jonsson, C. B., L. T. Figueiredo, and O. Vapalahti. 2010. A global perspective on hantavirus ecology, epidemiology, and disease. Clin. Microbiol. Rev. 23: 412-441.
133. Klein, S. L., B. H. Bird, and G. E. Glass. 2001. Sex differences in immune responses and viral shedding following Seoul virus infection in Norway rats. Am. J. Trop. Med. Hyg. 65: 57-63.
134. Easterbrook, J. D., and S. L. Klein. 2008. Corticosteroids modulate Seoul virus infection, regulatory T-cell responses and matrix metalloprotease 9 expression in male, but not female, Norway rats. J. Gen. Virol. 89: 2723-2730.
135. Klein, S. L., A. Cernetich, S. Hilmer, E. P. Hoffman, A. L. Scott, and G. E. Glass. 2004. Differential expression of immunoregulatory genes in male and female Norway rats following infection with Seoul virus. J. Med. Virol. 74: 180-190.
136. Vapalahti, O., J. Mustonen, A. Lundkvist, H. Henttonen, A. Plyusnin, and A. Vaheri. 2003. Hantavirus infections in Europe. Lancet Infect. Dis. 3: 653-661.
137. Ahlm, C., M. Linderholm, P. Juto, B. Stegmayr, and B. Settergren. 1994. Prevalence of serum IgG antibodies to Puumala virus (haemorrhagic fever with renal syndrome) in northern Sweden. Epidemiol. Infect. 113: 129-136.
138. Robinson, D. P., S. A. Huber, M. Moussawi, B. Roberts, C. Teuscher, R. Watkins, A. P. Arnold, and S. L. Klein. 2011. Sex chromosome complement contributes to sex differences in coxsackievirus B3 but not influenza A virus pathogenesis. Biol. Sex Differ. 2: 8.
139. Huber, S. A., and B. Pfaeffle. 1994. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J. Virol. 68: 5126-5132.
140. Kallewaard, N. L., L. Zhang, J. W. Chen, M. Guttenberg, M. D. Sanchez, and J. M. Bergelson. 2009. Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis. Cell Host Microbe 6: 91-98.
141. Li, Z., Y. Yue, and S. Xiong. 2013. Distinct Th17 inductions contribute to the gender bias in CVB3-induced myocarditis. Cardiovasc. Pathol. 22: 373-382.
142. Frisancho-Kiss, S., J. F. Nyland, S. E. Davis, J. A. Frisancho, M. A. Barrett, N. R. Rose, and D. Fairweather. 2006. Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rbeta1 signaling and IFN-gamma increase inflammation in males independent from STAT4. Brain Res. 1126: 139-147.
143. Klein, S. L., and A. Pekosz. 2014. Sex-based biology and the rational design of influenza vaccination strategies. J. Infect. Dis. 209(Suppl. 3): S114-S119.
144. Klein, S. L., C. Passaretti, M. Anker, P. Olukoya, and A. Pekosz. 2010. The impact of sex, gender and pregnancy on 2009 H1N1 disease. Biol. Sex Differ. 1: 5.
145. Klein, S. L., A. Hodgson, and D. P. Robinson. 2012. Mechanisms of sex disparities in influenza pathogenesis. J. Leukoc. Biol. 92: 67-73.
146. Torcia, M. G., L. Nencioni, A. M. Clemente, L. Civitelli, I. Celestino, D. Limongi, G. Fadigati, E. Perissi, F. Cozzolino, E. Garaci, and A. T. Palamara. 2012. Sex differences in the response to viral infections: TLR8 and TLR9 ligand stimulation induce higher IL10 production in males. PLoS One 7: e39853.
147. Gilliver, S. C. 2010. Sex steroids as inflammatory regulators. J. Steroid Biochem. Mol. Biol. 120: 105-115.
148. Hoffmann, J., A. Otte, S. Thiele, H. Lotter, Y. Shu, and G. Gabriel. 2015. Sex differences in H7N9 influenza A virus pathogenesis. Vaccine 33: 6949-6954.
149. Sterling, T. R., D. Vlahov, J. Astemborski, D. R. Hoover, J. B. Margolick, and T. C. Quinn. 2001. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N. Engl. J. Med. 344: 720-725.
150. Sterling, T. R., C. M. Lyles, D. Vlahov, J. Astemborski, J. B. Margolick, and T. C. Quinn. 1999. Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters. J. Infect. Dis. 180: 666-672.
151. Ziegler, S., and M. Altfeld. 2016. Sex differences in HIV-1-mediated immunopathology. Curr. Opin. HIV AIDS 11: 209-215.
152. Sterling, T. R., T. Pisell-Noland, J. L. Perez, J. Astemborski, J. R. McGriff, L. Nutting, D. R. Hoover, D. Vlahov, and R. C. Bollinger. 2005. Sex-based differences in T lymphocyte responses in HIV-1-seropositive individuals. J. Infect. Dis. 191: 881-885.
153. Li, G., M. Cheng, J. Nunoya, L. Cheng, H. Guo, H. Yu, Y. J. Liu, L. Su, and L. Zhang. 2014. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 10: e1004291.
154. Tsao, L. C., H. Guo, J. Jeffrey, J. A. Hoxie, and L. Su. 2016. CCR5 interaction with HIV-1 Env contributes to Env-induced depletion of CD4 T cells in vitro and in vivo. Retrovirology 13: 22.
155. Monroe, A. K., A. S. Dobs, X. Xu, F. J. Palella, L. A. Kingsley, M. D. Witt, and T. T. Brown. 2011. Sex hormones, insulin resistance, and diabetes mellitus among men with or at risk for HIV infection. J. Acquir. Immune Defic. Syndr. 58: 173-180.
156. Martin, M. E., C. Benassayag, C. Amiel, P. Canton, and E. A. Nunez. 1992. Alterations in the concentrations and binding properties of sex steroid binding protein and corticosteroid-binding globulin in HIV+patients. J. Endocrinol. Invest. 15: 597-603.
157. Laffont, S., N. Rouquié, P. Azar, C. Seillet, J. Plumas, C. Aspord, and J. C. Guéry. 2014. X-Chromosome complement and estrogen receptor signaling independently contribute to the enhanced TLR7-mediated IFN-a production of plasmacytoid dendritic cells from women. J. Immunol. 193: 5444-5452.
158. Lindsey, N. P., B. A. Schroeder, E. R. Miller, M. M. Braun, A. F. Hinckley, N. Marano, B. A. Slade, E. D. Barnett, G. W. Brunette, K. Horan, et al. 2008. Adverse event reports following yellow fever vaccination. Vaccine 26: 6077-6082.